Last reviewed · How we verify
NCT05483881
the Effects of Air Pollution on Respiratory Diseases in Children
trial in Respiratory Disease in 2,000,000 participants. Status unknown.
31 December 2022
Quick facts
| Lead sponsor | Beijing Children's Hospital |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 2,000,000 |
| Start date | 15 May 2022 |
| Primary completion | 31 December 2022 |
| Estimated completion | 31 December 2022 |
| Sites | 1 location across China |
Conditions studied
- Respiratory Disease — all drugs for Respiratory Disease →
Sponsor
Beijing Children's Hospital
Who can join
Adults 1 Day to 18, any sex, with Respiratory Disease. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The investigators expect to reveal the association between air pollution and childhood respiratory diseases through a multi-center observational study, and summarize the relationship between air pollution and childhood respiratory diseases.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05483881
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Respiratory Disease
Currently open trials in the same condition.
- NCT06716502 — A New Portable Device for Non-invasive Ventilatory Support · NA · recruiting
- NCT06455033 — Manual Diaphragm Release on Stepping Reaction Time in Chronic Obstructive Pulmonary Disease · NA · active not recruiting
- NCT06796894 — Symptoms, Respiratory Dysfunction and Frailty Level in Allergic and Eosonophilic Asthmatics · recruiting
- NCT06503913 — Cognitive Muscular Therapy for Patients With Long-COVID and Breathing Pattern Disorder · NA · active not recruiting
- NCT06569940 — Sleepiz One+ vs. Capnography and Electrocardiography · NA · recruiting
Other Beijing Children's Hospital trials
Trials by the same sponsor.
- NCT07412119 — Research on Disease Control and Mental Health Status of Adolescent Asthma Patients · not yet recruiting
- NCT06837584 — Control and Treatment of Outpatient Children With Asthma · not yet recruiting
- NCT07199101 — Multicenter Pediatric Low-Dose CT Protocol: Development and Clinical Verification · NA · not yet recruiting
- NCT07488728 — Letermovir Prophylaxis in Children With EBV-Positive T/NK-Cell Lymphoproliferative Disease and Refractory/Relapsed EBV-A · NA · recruiting
- NCT07029958 — Improved Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation Protocol for the Treatment of Epstein Barr Vir · Phase 4 · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05483881 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Beijing Children's Hospital
- Last refreshed: 2 August 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05483881.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing